FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape

BACKGROUND. With the exception of trastuzumab, therapies directed at receptor tyrosine kinases (RTKs) in gastroesophageal adenocarcinomas (GEA) have had limited success. Recurrent fibroblast growth factor receptor 2 (FGFR2) alterations exist in GEA; however, little is known about the genomic landsca...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncologist
Main Authors: Klempner, Samuel J., Madison, Russell, Pujara, Vivek, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Schrock, Alexa B., Kim, Seung Tae, Maron, Steven B., Dayyani, Farshid, Catenacci, Daniel V.T., Lee, Jeeyun, Chao, Joseph
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Inc. 2019
主題:
Gastrointestinal Cancer
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853122/
https://ncbi.nlm.nih.gov/pubmed/31249137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0121
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍